These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 2545918)

  • 1. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
    Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
    J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.
    Felser JM; Klimkait T; Silver J
    Virology; 1989 Jun; 170(2):566-70. PubMed ID: 2543131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.
    Dowbenko D; Nakamura G; Fennie C; Shimasaki C; Riddle L; Harris R; Gregory T; Lasky L
    J Virol; 1988 Dec; 62(12):4703-11. PubMed ID: 2460639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transport.
    Dewar RL; Vasudevachari MB; Natarajan V; Salzman NP
    J Virol; 1989 Jun; 63(6):2452-6. PubMed ID: 2542563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus.
    Dewar RL; Natarajan V; Vasudevachari MB; Salzman NP
    J Virol; 1989 Jan; 63(1):129-36. PubMed ID: 2535720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.
    Berman PW; Nunes WM; Haffar OK
    J Virol; 1988 Sep; 62(9):3135-42. PubMed ID: 2841466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the highly conserved N-glycan at Asn260 of HIV-1 gp120 affects folding and lysosomal degradation of gp120, and results in loss of viral infectivity.
    Mathys L; François KO; Quandte M; Braakman I; Balzarini J
    PLoS One; 2014; 9(6):e101181. PubMed ID: 24967714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
    Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.
    Willey RL; Bonifacino JS; Potts BJ; Martin MA; Klausner RD
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9580-4. PubMed ID: 2849111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
    Freed EO; Myers DJ; Risser R
    J Virol; 1989 Nov; 63(11):4670-5. PubMed ID: 2677400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved antigenicity of the HIV env protein by cleavage site removal.
    Kieny MP; Lathe R; Rivière Y; Dott K; Schmitt D; Girard M; Montagnier L; Lecocq J
    Protein Eng; 1988 Sep; 2(3):219-25. PubMed ID: 3237686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120.
    Thiriart C; Francotte M; Cohen J; Collignon C; Delers A; Kummert S; Molitor C; Gilles D; Roelants P; van Wijnendaele F
    J Immunol; 1989 Sep; 143(6):1832-6. PubMed ID: 2476484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type-1 envelope glycoprotein gp120 induces expression of fusion regulatory protein (FRP)-1/CD98 on CD4+ T cells: a possible regulatory mechanism of HIV-induced syncytium formation.
    Suga S; Tsurudome M; Ito M; Ohgimoto S; Tabata N; Nishio M; Kawano M; Komada H; Ito M; Sakurai M; Ito Y
    Med Microbiol Immunol; 1997 Mar; 185(4):237-43. PubMed ID: 9138296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.
    Fenouillet E; Clerget-Raslain B; Gluckman JC; Guétard D; Montagnier L; Bahraoui E
    J Exp Med; 1989 Mar; 169(3):807-22. PubMed ID: 2538547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal 31 amino acids of human immunodeficiency virus type 1 envelope protein gp120 contain a potential gp41 contact site.
    Ivey-Hoyle M; Clark RK; Rosenberg M
    J Virol; 1991 May; 65(5):2682-5. PubMed ID: 2016774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
    Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
    J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.